Subscribe to RSS
Pictorial Depiction of an Institutional Experience of Acute Abdominal Emergencies in Cancer Patients with COVID-19 InfectionFunding None.
The ongoing pandemic of coronavirus disease 2019 (COVID-19) poses a diagnostic and management challenge to the clinician, which further gets heightened when patients present with abdominal complications in a cancer care center. The atypical manifestations of the disease provide a diagnostic conundrum to the radiologist and leave the pathologist in the perils of guiding further management to the clinician. Although previous literature shows gastrointestinal involvement in COVID-19, we present a case series of complicated subjects with clinical imaging as a pictorial essay and relevant pathology. The abdominal manifestations of COVID-19 are complicated in cancer patients where a variety of other differentials such as infiltration by metastatic disease and drug-related chemo toxicity effects must be taken into account, which may be ruled out by clinical workup, adequate imaging, and laboratory tests. This would help achieve better clinical acumen and modify management in these subjects.
Article published online:
09 February 2022
© 2022. Indian Society of Gastrointestinal and Abdominal Radiology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
- 1 Phelan AL, Katz R, Gostin LO. The novel coronavirus originating in Wuhan, China: challenges for global health governance. JAMA 2020; 323 (08) 709-710
- 2 Gao Y, Xi H, Chen L. Emergency surgery in suspected COVID-19 patients with acute abdomen: case series and perspectives. Ann Surg 2020; 272 (01) e38-e39
- 3 Rokkas T. Gastrointestinal involvement in COVID-19: a systematic review and meta-analysis. Ann Gastroenterol 2020; 33 (04) 355-365
- 4 Effenberger M, Grabherr F, Mayr L. et al. Faecal calprotectin indicates intestinal inflammation in COVID-19. Gut 2020; 69 (08) 1543-1544
- 5 De Nardi P, Parolini DC, Ripa M, Racca S, Rosati R. Bowel perforation in a Covid-19 patient: case report. Int J Colorectal Dis 2020; 35 (09) 1797-1800
- 6 Xiong XL, Wong KK, Chi SQ. et al. Comparative study of the clinical characteristics and epidemiological trend of 244 COVID-19 infected children with or without GI symptoms. Gut 2021; 70 (02) 436-438
- 7 Zhang Y, Xiao M, Zhang S. et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med 2020; 382 (17) e38
- 8 Bianco F, Ranieri AJ, Paterniti G, Pata F, Gallo G. Acute intestinal ischemia in a patient with COVID-19. Tech Coloproctol 2020; 24 (11) 1217-1218
- 9 Gartland RM, Velmahos GC. Bowel necrosis in the setting of COVID-19. J Gastrointest Surg 2020; 24 (12) 2888-2889
- 10 Conde Cardona G, Quintana Pájaro LD, Quintero Marzola ID, Ramos Villegas Y, Moscote Salazar LR. Neurotropism of SARS-CoV 2: mechanisms and manifestations. J Neurol Sci 2020; 412: 116824
- 11 Guan WJ, Ni ZY, Hu Y. et al; China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382 (18) 1708-1720
- 12 Panigada M, Bottino N, Tagliabue P. et al. Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost 2020; 18 (07) 1738-1742